Literature DB >> 11051033

Clinical implications of biocompatibility in blood purification membranes.

R M Hakim1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11051033     DOI： 10.1093/ndt/15.suppl_1.16

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

1.  Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis.

Authors:  Helton P Lemes; Salustiano Araujo; Daniella Nascimento; Danny Cunha; Cesar Garcia; Vinicius Queiroz; Sebastião R Ferreira-Filho
Journal:  Clin Exp Nephrol       Date:  2011-03-18       Impact factor: 2.801

Review 2.  Promoting Kidney Function Recovery in Patients with AKI Requiring RRT.

Authors:  Jorge Cerdá; Kathleen D Liu; Dinna N Cruz; Bertrand L Jaber; Jay L Koyner; Michael Heung; Mark D Okusa; Sarah Faubel
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 8.237

Review 3.  Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease.

Authors:  Xin Liu; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2016-09-07

4.  Performance and Hemocompatibility of a Novel Polysulfone Dialyzer: A Randomized Controlled Trial.

Authors:  Götz Ehlerding; Ansgar Erlenkötter; Adelheid Gauly; Bettina Griesshaber; James Kennedy; Lena Rauber; Wolfgang Ries; Hans Schmidt-Gürtler; Manuela Stauss-Grabo; Stephan Wagner; Adam M Zawada; Sebastian Zschätzsch; Manuela Kempkes-Koch
Journal:  Kidney360       Date:  2021-04-07

5.  Thrombopoietic status of patients on haemodialysis.

Authors:  Taha Bat; Betul E Bat; Ahmed El-Moghraby; Samir Patel; Xingmin Feng; Cynthia E Dunbar; Erdal Sarac
Journal:  Br J Haematol       Date:  2016-02-16       Impact factor: 6.998

6.  Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis.

Authors:  Taro Fukushi; Tae Yamamoto; Mai Yoshida; Emi Fujikura; Mariko Miyazaki; Masaaki Nakayama
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.